LA ROCHE-POSAY | EFFACLAR MAT
LA ROCHE-POSAY | EFFACLAR MAT
This hypoallergenic and non-comedogenic formula harnesses ‘Sebulyse’ to reduce and control excess sebum production, giving back oil-prone skin types control over their skin.
Oil-free hydration has never felt so good thanks to La Roche-Posay and their tried and tested Effaclar range. Gone are the days of blotting papers and hourly touch-ups, this even doubles up as the perfect primer under make up! Add in skin-conditioning active zinc PCA to fend off ageing aggressors and our old-faithful salicylic acid to keep pores visibly reduced and clear this is climbing the charts of our Holy Grail mattifying moisturisers.
Share
Ingredients
Ingredients
Aqua/Water, Cyclopentasiloxane, Glycerin, Isocetyl Stearate, Alcohol Denat., Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, Acrylamide/Sodium Acryloyldimethyltaurate Copolymer, Methyl Methacrylate Crosspolymer, Silica, Cyclohexasiloxane, Peg-100 Sterate, Cocamide Mea, Zinc Pca, Glyceryl Stearate, Triethanolamine, Isohexadecane, Sodium Citrate, Ascorbyl Glucoside, Nylon-12, Capryloyl Salicylic Acid, Tetrasodium Edta, Polysorbate 80, Acrylates/C10-30 Alyl Acrylate Crosspolymer, Tocopherol, Methylparaben, Salicylic Acid, Parfum/Fragrance.
How to use
How to use
Apply to face and neck morning and/or evening after cleansing.
Description
Description
This hypoallergenic and non-comedogenic formula harnesses ‘Sebulyse’ to reduce and control excess sebum production, giving back oil-prone skin types control over their skin.
Oil-free hydration has never felt so good thanks to La Roche-Posay and their tried and tested Effaclar range. Gone are the days of blotting papers and hourly touch-ups, this even doubles up as the perfect primer under make up! Add in skin-conditioning active zinc PCA to fend off ageing aggressors and our old-faithful salicylic acid to keep pores visibly reduced and clear this is climbing the charts of our Holy Grail mattifying moisturisers.
Subscribe to our emails
Join our email list for exclusive offers and the latest news.